Exascale Labs Holdings Inc. (Class A) (XLAB) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 23% of 52W Range • RSI-14 at 51 (NEUTRAL RANGE)
20D Institutional Volume Accumulation (±12.5% realized swing band)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
While XLAB currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.06) and Max Pain ($3.31) forces dealer call-delta covering toward $11.73.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Exascale Labs Holdings Inc. (Class A) (XLAB) slipped -0.63% to $3.15, trading at 23% of its 52-week range ($0.78 – $11.17). Stretched risk/reward at current multiples (-24% return on capital) under elevated 10-year interest-rate pressure.
Gainers Braiin (NASDAQ:BRAI) stock increased by 90.1% to $4.03 during Tuesday's regular session. The company's market cap stands at $436.9 million. AudioEye (NASDAQ:AEYE) shares rose 33.96% to $9.94. The
Gainers ClearOne (NASDAQ:CLRO) stock rose 63.5% to $3.14 during Friday's regular session. The company's market cap stands at $4.7 million. BIO-key International (NASDAQ:BKYI) shares rose 32.1% to $3.62. The
Gainers Exascale Labs Holdings (NASDAQ:XLAB) stock increased by 31.6% to $3.58 during Thursday's regular session. The market value of their outstanding shares is at $192.3 million. BIO-key International
Gainers BIO-key International (NASDAQ:BKYI) stock increased by 26.7% to $2.66 during Thursday's pre-market session. The company's market cap stands at $4.6 million. ARB IOT Group (NASDAQ:ARBB) stock increased
Gainers Alpha Modus Holdings (NASDAQ:AMOD) shares moved upwards by 61.6% to $2.08 during Wednesday's regular session. The market value of their outstanding shares is at $5.9 million. Amplitech Group, Inc. - Series
Gainers XIAO-I (NASDAQ:AIXI) shares rose 26.2% to $2.78 during Tuesday's pre-market session. The company's market cap stands at $29.0 million. ARB IOT Group (NASDAQ:ARBB) shares increased by 15.08% to $4.5.
Gainers BitFuFu (NASDAQ:FUFU) stock rose 37.8% to $1.24 during Monday's regular session. The market value of their outstanding shares is at $218.3 million. Bitzero Holdings (NASDAQ:AIBZ) shares moved upwards by
Gainers Amplitech Group, Inc. - Series B Right (NASDAQ:AMPGZ) shares moved upwards by 31.7% to $0.13 during Monday's pre-market session. 3 E Network (NASDAQ:MASK) shares moved upwards by 30.54% to $1.05. The
Exascale Labs (NASDAQ: XLAB) trades up 27% premarket. Read about its 111% revenue growth, AI compute deals, and fiscal 2027 outlook.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on XLAB today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for XLAB. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, Exascale Labs Holdings Inc. (Class A) (XLAB) ranks #590 by composite RQD confidence (37/100, grade D-) and #476 by equity capitalization ($202.7M). Within this direct 5-issuer industry benchmark cohort, XLAB leads on earnings valuation at N/A trailing P/E, while DUOT leads on capital efficiency and profitability with -15.9% ROIC and 29.2% gross margin. ZENA currently holds the highest overall quantitative score in the immediate peer group at 54/100 (D+) compared with XLAB at 37/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| XLAB
ACTIVE
Exascale Labs Holdings Inc. (Class A) | D- | 37/100 | — | 15.8% | -23.7% | -0.63% | $202.7M | Benchmark Subject |
| DUOT Duos Technologies Group Inc. | D- | 40/100 | — | 29.2% | -15.9% | +0.47% | $203.3M | /duot-vs-xlab → |
| GIBO GIBO Holdings Limited (Class A) | D | 45/100 | — | — | -35.0% | +2.42% | $192.2M | /gibo-vs-xlab → |
| ZENA ZenaTech Inc. | D+ | 54/100 | — | — | — | -0.05% | $185.8M | /zena-vs-xlab → |
| EXFY Expensify Inc. (Class A) | D | 46/100 | — | 50.3% | -20.4% | -2.41% | $221.6M | /exfy-vs-xlab → |
In its most recent audited fiscal period (FY2025, filed 2025-06-30), Exascale Labs Holdings Inc. (Class A) (XLAB) reported GAAP revenue of $7.0M , GAAP net income of -$7.7M, operating cash flow of -$1.0M, and free cash flow of -$1.0M . On the balance sheet, XLAB closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $7.0M | -$7.7M | -$1.0M | -$1.0M | — | — |
As of 2026-11-01, Exascale Labs Holdings Inc. (Class A) (NASDAQ: XLAB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $3.15 (-0.63% 1D, market cap $202.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, XLAB ranks #590 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), XLAB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 15.8%, and ROIC of -23.7%. By comparison, DUOT (Duos Technologies Group Inc.) holds a D- grade (40/100 RQD, P/E N/A, ROIC -15.9%, cap $203.3M) and GIBO (GIBO Holdings Limited (Class A)) posts a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $192.2M). Among the 5-stock peer group, XLAB leads on earnings multiple (N/A) while DUOT leads on capital efficiency (-15.9% ROIC).
Per XLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0002109869), Exascale Labs Holdings Inc. (Class A) generated $7.0M in revenue, -$7.7M in net income, and -$1.0M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
XLAB last traded at $3.15 (-0.63% on volume of 1,251,708 shares), positioning the stock +2.94% above its 50-day simple moving average ($3.06) and -60.77% below its 200-day simple moving average ($8.03). Across its 52-week range of $0.78 to $11.17, XLAB sits at the 22.8% percentile with a 14-day RSI of 51.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.76 to $3.54).
Why XLAB Stock slipped -0.63% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-24% return on capital) under elevated 10-year interest-rate pressure.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.